A randomized study of KRAS-guided maintenance therapy with bevacizumab, erlotinib or metronomic capecitabine after first line induction treatment of metastatic colorectal cancer: the Nordic ACT2 trial

Helga Hagman, Jan-Erik Frödin, Åke Berglund, Jan Sundberg, Lene Vestermark, Maria Albertsson, Eva Fernebro, Anders Johnsson

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskriftPeer review

34 Citeringar (SciVal)
Filter
Doktorsavhandling (sammanläggning)

Sökresultat